CHAMPION PLATFORM
- 5,362 participants
- 4 sites in New Zealand
- 218 sites in 18 countries
CHAMPION Platform – Cangrelor versus standard therapy to achieve optimal management of platelet inhibition
This is a phase III clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention. The primary objective is to demonstrate that the efficacy of cangrelor (combined with usual care is superior to that of usual care, in subjects requiring PCI as measured by a composite of all-cause mortality, MI and IDR.